We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FROG:NASDAQJFrog Ltd. Analysis

Data as of 2026-06-07 - not real-time

$84.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

JFrog (FROG) is trading well above its 20‑day SMA of 74.35 and the 200‑day SMA of 53.85, with the price at 84 and a bullish MACD crossover (MACD line 8.18 > signal 7.51). The RSI of 69 signals near‑overbought conditions, while volume is trending lower and 30‑day volatility remains elevated at 82.9%, suggesting a short‑term pull‑back risk. The stock’s DCF fair value of 56.66 is well below the current price, yielding a ‑3.9% downside and a forward P/E of 74.8×, indicating that the market is pricing in strong growth but may be overvalued.
Fundamentally, revenue surged 25.8% YoY to $154 M, gross margins stay robust at 77%, and the company generated positive operating cash flow of $155 M and free cash flow of $170 M, backed by $741 M of cash and minimal debt. Recent Q1 2026 results beat expectations, delivering non‑GAAP EPS of $0.27 versus consensus and raising guidance for the next quarter, while analysts have a “strong buy” consensus with a median target of $80, slightly below the current price. The combination of rapid top‑line growth, a cash‑rich balance sheet, and expanding AI/ML pipeline opportunities supports a longer‑term growth narrative, though profitability remains elusive with a negative operating margin of ‑7.4%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI near overbought and price approaching resistance
  • High short‑term volatility and decreasing volume
  • Recent earnings beat but limited margin improvement

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained revenue growth above 25% YoY
  • Strong cash generation and low net debt
  • Positive guidance and expanding AI/ML product suite

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic positioning in the software supply‑chain market
  • Long‑term demand for secure DevSecOps and AI/ML pipelines
  • Potential margin expansion as scale drives operating efficiencies

Key Metrics & Analysis

Financial Health

Revenue Growth25.80%
Profit Margin-10.93%
P/E Ratio74.8
ROE-7.14%
ROA-3.73%
Debt/Equity1.78
P/B Ratio11.0
Op. Cash Flow$155.3M
Free Cash Flow$169.9M
Industry P/E32.6

Technical Analysis

TrendBullish
RSI69.1
Support$62.01
Resistance$89.16
MA 20$74.35
MA 50$57.97
MA 200$53.85
MACDBullish
VolumeDecreasing
Fear & Greed Index83.02

Valuation

Fair Value$56.66
Target Price$80.75
Upside/Downside-3.87%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.35
Volatility82.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.